- Home
- TEVA vs VRSN Comparison
TEVA vs VRSN Comparison
Compare TEVA & VRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- VRSN
- Stock Information
- Founded
- TEVA 1901
- VRSN 1995
- Country
- TEVA Israel
- VRSN United States
- Employees
- TEVA N/A
- VRSN N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- VRSN EDP Services
- Sector
- TEVA Health Care
- VRSN Technology
- Exchange
- TEVA Nasdaq
- VRSN Nasdaq
- Market Cap
- TEVA 19.7B
- VRSN 18.3B
- IPO Year
- TEVA N/A
- VRSN 1998
- Fundamental
- Price
- TEVA $18.38
- VRSN $186.92
- Analyst Decision
- TEVA Strong Buy
- VRSN Buy
- Analyst Count
- TEVA 8
- VRSN 2
- Target Price
- TEVA $19.25
- VRSN $218.00
- AVG Volume (30 Days)
- TEVA 4.9M
- VRSN 515.3K
- Earning Date
- TEVA 11-06-2024
- VRSN 10-24-2024
- Dividend Yield
- TEVA N/A
- VRSN N/A
- EPS Growth
- TEVA N/A
- VRSN 23.38
- EPS
- TEVA N/A
- VRSN 8.36
- Revenue
- TEVA $16,290,000,000.00
- VRSN $1,528,100,000.00
- Revenue This Year
- TEVA $4.59
- VRSN $6.56
- Revenue Next Year
- TEVA $4.06
- VRSN $3.71
- P/E Ratio
- TEVA N/A
- VRSN $22.40
- Revenue Growth
- TEVA 8.48
- VRSN 4.49
- 52 Week Low
- TEVA $8.07
- VRSN $167.05
- 52 Week High
- TEVA $19.08
- VRSN $220.91
- Technical
- Relative Strength Index (RSI)
- TEVA 59.65
- VRSN 50.86
- Support Level
- TEVA $17.73
- VRSN $185.46
- Resistance Level
- TEVA $18.33
- VRSN $188.24
- Average True Range (ATR)
- TEVA 0.38
- VRSN 2.24
- MACD
- TEVA 0.10
- VRSN -0.25
- Stochastic Oscillator
- TEVA 93.00
- VRSN 29.61
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About VRSN VeriSign Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.